Preparation of Defect-Related Luminescent Mesoporous Silica Nanoparticle as Potential Detectable Drug Carrier

2020 ◽  
Vol 20 (12) ◽  
pp. 7362-7368
Author(s):  
Yongju He ◽  
Hui Xu ◽  
Shuquan Liang

A defect-related luminescent mesoporous silica nanoparticle (DLMSN) with simultaneous excellent luminescence, high drug loading efficiency and release capacity was prepared upon calcination of 3-aminopropyltriethoxysilane (APTES)-functionalized mesoporous silica nanoparticle (AP-MSN) under a relatively moderate temperature. Under ultraviolet excitation at 365 nm, DLMSN exhibited intense white-blue emission with a range of 400–500 nm, which was inferred to originate from the effective carbon or nitrogen defect in the particle causing by APTES calcination. Additionally, the luminescence intensity of DLMSN was significantly affected by APTES concentration and calcination temperature during the preparation procedure. Within all the tested values, the maximum luminescence intensity was achieved when APTES concentration and calcination temperature were 0.851 mmol and 300 °C, respectively. The drug storage and release tests demonstrated that DLMSN had efficient drug storage and good pH-dependent release for ibuprofen (IBU). Interestingly, ibuprofen-loaded DLMSN (IBU@DLMSN) still exhibit an intense luminescence with an emission peak at around 410 nm under 365 nm excitation, which gradually increased with the sustained release of IBU from IBU@DLMSN. These results suggest that the as-prepared DLMSN may have potential as a detectable nanocarrier in the drug delivery field.

2020 ◽  
Vol 59 (14) ◽  
pp. 10275-10284 ◽  
Author(s):  
Marina Martínez-Carmona ◽  
Quy P. Ho ◽  
Jérémy Morand ◽  
Ana García ◽  
Enrique Ortega ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (39) ◽  
pp. 30640-30646 ◽  
Author(s):  
Yue Yan ◽  
Jie Fu ◽  
Xin Liu ◽  
Tianfu Wang ◽  
Xiuyang Lu

An intracellular acidity-triggered doxorubicin release from “click chemistry” functionalized mesoporous silica nanoparticle was demonstrated.


2012 ◽  
Vol 22 (17) ◽  
pp. 3576-3582 ◽  
Author(s):  
Susana Martin-Ortigosa ◽  
Justin S. Valenstein ◽  
Victor S.-Y. Lin ◽  
Brian G. Trewyn ◽  
Kan Wang

Author(s):  
Han Wu ◽  
Xin-Fei Xu ◽  
Jia-Qi Zhu ◽  
Ming-Da Wang ◽  
Chao Li ◽  
...  

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related death worldwide, which lacks effective inhibition of progression and metastasis in the advanced clinical stage. Mesoporous silica nanoparticle (MSN)–based cytotoxic or immunoregulatory drug–loading strategies have attracted widespread attention in the recent years. As a representative of mesoporous biomaterials, MSNs have good biological characteristics and immune activation potential and can cooperate with adjuvants against HCC. This review summarizes the possible future development of the field from the perspective of tumor immunity and aims to stimulate the exploration of the immune mechanism of MSN-based therapy. Through this point of view, we hope to develop new clinical immune drugs that can be applied to HCC clinical management in the future.


Sign in / Sign up

Export Citation Format

Share Document